AUTOMA+ 2026
AUTOMA+ 2026 (Zurich, 16-17 November) focuses on digital instruments for the pharma industry. The agenda covers AI, Pharma 4.0, digital factories and GxP-ready solutions, with participants from GSK, Takeda, Novartis, WHO, Emerson and others.
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026
November 16-17, 2026
Zurich, Switzerland
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026 is a closed-door event that focuses on the end-to-end digital transformation - from R&D and laboratory automation to manufacturing, packaging, supply chain, compliance and commercial operations. Hosted in Zurich on 16-17 November 2026, the Congress addresses the real constraints shaping digital transformation in pharma - from data integrity and validation to scalability and return on investment.
More than 50 speakers contribute to the agenda, covering:
- Pharma 4.0 with AI and advanced analytics;
- R&D and laboratory automation;
- next-generation digital solutions for GxP compliance;
- quality management and modification of pharma logistics;
- patient-centric digital commercial and marketing strategies;
- real-world data applications and others.
AUTOMA+ 2026 features perspectives from GSK, Takeda, Novartis, Roche, Johnson & Johnson, SCARLETRED Holding GmbH, WHO and others, reflecting a cross-section of pharmaceutical manufacturing, research, public health and technology expertise. With its focus on applied use cases, AUTOMA+ 2026 demonstrates the practical implementation of automation and digitalisation across regulated pharmaceutical environments today.
Please verify dates, venue, and schedule details directly with the official event website, as information is subject to change by the organiser.